Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$26.12 - $34.07 $89,931 - $117,303
-3,443 Reduced 16.4%
17,547 $597,000
Q1 2024

May 15, 2024

SELL
$26.64 - $40.31 $2,930 - $4,434
-110 Reduced 0.52%
20,990 $738,000
Q4 2023

Feb 14, 2024

BUY
$19.95 - $31.0 $55,740 - $86,614
2,794 Added 15.26%
21,100 $609,000
Q3 2023

Nov 09, 2023

BUY
$21.33 - $59.42 $68,938 - $192,045
3,232 Added 21.44%
18,306 $419,000
Q2 2023

Aug 14, 2023

SELL
$34.33 - $62.11 $226,749 - $410,236
-6,605 Reduced 30.47%
15,074 $864,000
Q1 2023

May 15, 2023

BUY
$26.01 - $48.69 $109,424 - $204,838
4,207 Added 24.08%
21,679 $815,000
Q4 2022

Feb 13, 2023

BUY
$24.14 - $30.37 $149,957 - $188,658
6,212 Added 55.17%
17,472 $467,000
Q3 2022

Nov 14, 2022

SELL
$22.23 - $33.37 $61,688 - $92,601
-2,775 Reduced 19.77%
11,260 $319,000
Q2 2022

Aug 11, 2022

BUY
$19.74 - $43.01 $12,890 - $28,085
653 Added 4.88%
14,035 $305,000
Q1 2022

May 13, 2022

SELL
$36.25 - $52.02 $48,756 - $69,966
-1,345 Reduced 9.13%
13,382 $537,000
Q4 2021

Feb 11, 2022

SELL
$43.27 - $65.72 $1.34 Million - $2.03 Million
-30,907 Reduced 67.73%
14,727 $698,000
Q3 2021

Nov 04, 2021

BUY
$53.61 - $67.5 $13,670 - $17,212
255 Added 0.56%
45,634 $2.58 Million
Q2 2021

Aug 11, 2021

BUY
$45.13 - $64.99 $169,733 - $244,427
3,761 Added 9.04%
45,379 $2.61 Million
Q1 2021

May 13, 2021

SELL
$29.77 - $84.85 $28,073 - $80,013
-943 Reduced 2.22%
41,618 $2.63 Million
Q4 2020

Feb 16, 2021

BUY
$25.66 - $34.55 $901,281 - $1.21 Million
35,124 Added 472.29%
42,561 $1.43 Million
Q3 2020

Nov 12, 2020

BUY
$22.51 - $30.11 $14,856 - $19,872
660 Added 9.74%
7,437 $203,000
Q2 2020

Aug 13, 2020

BUY
$12.65 - $29.57 $42,061 - $98,320
3,325 Added 96.32%
6,777 $184,000
Q1 2020

May 14, 2020

BUY
$10.84 - $20.85 $18,894 - $36,341
1,743 Added 101.99%
3,452 $51,000
Q4 2019

Feb 14, 2020

BUY
$13.02 - $19.5 $4,478 - $6,708
344 Added 25.2%
1,709 $28,000
Q3 2019

Nov 14, 2019

BUY
$17.46 - $29.05 $23,832 - $39,653
1,365 New
1,365 $24,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.